These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 231568)

  • 1. Artificial beta-cell application in two cases of insulinoma: a different pattern in beta-cell adenoma and carcinoma.
    Brunetti P; Santeusanio F; Puxeddu A; Massi-Benedetti M; Calabrese G; Angeletti G; Bueti A; Scionti L; De Angelis M
    Horm Metab Res Suppl; 1979; (8):173-7. PubMed ID: 231568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
    Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
    Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Localization of beta-Langerhans tumors secreting hypoglycemics].
    Turner RC; Dick R; Lee EC
    Journ Annu Diabetol Hotel Dieu; 1983; ():131-8. PubMed ID: 6139498
    [No Abstract]   [Full Text] [Related]  

  • 6. Anomalous glucose and insulin responses in patients with insulinoma. Caveats for diagnosis.
    Dons RF; Hodge J; Ginsberg BH; Brennan MF; Cryer PE; Kourides IA; Gorden P
    Arch Intern Med; 1985 Oct; 145(10):1861-3. PubMed ID: 2994586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biostator glucose controller. Its use during surgical removal of an insulinoma.
    Jorgensen RG; Friesen SR; Lukert B; Moore WV
    J Kans Med Soc; 1983 Nov; 84(11):563-5. PubMed ID: 6315835
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the artificial pancreas in the diagnosis and management of an insulinoma (author's transl)].
    Buysschaert M; Lambotte L; Rahier J; Kestens PJ; Lambert AE
    Ann Endocrinol (Paris); 1980; 41(3):227-8. PubMed ID: 6251746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of the artificial pancreas in the diagnosis and surgical treatment of insulinomas].
    Parneix M; Rullier E; Gin H; Roche A
    Ann Chir; 1994; 48(5):421-9. PubMed ID: 7810974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-clamp by artificial pancreas in the study and management of a patient with insulinoma.
    Saibene V; Alberetto M; Dossi G; Andreoni B; Cordaro C; Vegeto G; Dabandi M
    Acta Diabetol Lat; 1981; 18(2):183-90. PubMed ID: 6264722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secreting langerhansian insulinoma. Clinical, biological, arteriographical and ultrastructural study of a case].
    Rochiccioli P; Delsol G; Juskiewinski S; Ghisolfi J; Ribot C; Gabarou JP; Fabre J; Dalous A
    Arch Fr Pediatr; 1971 Dec; 28(10):1041-56. PubMed ID: 4338621
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs.
    Leifer CE; Peterson ME; Matus RE
    J Am Vet Med Assoc; 1986 Jan; 188(1):60-4. PubMed ID: 3003016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in the management of insulinoma.
    Chong PN; Cheah JS; Ng SC; Tan L; Thai AC; Rauff A; Yeo PP
    Singapore Med J; 1985 Jun; 26(3):312-5. PubMed ID: 2996151
    [No Abstract]   [Full Text] [Related]  

  • 18. Functioning insulinoma with a twenty-year history.
    Rubio PA; Orzeck EA; Farrell EM
    Int Surg; 1985; 70(3):267-70. PubMed ID: 3011698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign insulinoma--a diagnostic challenge: a case report.
    Fock KM; Nambiar R
    Med J Malaysia; 1984 Jun; 39(2):170-2. PubMed ID: 6096683
    [No Abstract]   [Full Text] [Related]  

  • 20. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.